Jun 12, 2019 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the Ziopharm Oncology Conference Call. (Operator Instructions)
I would now like to turn the conference over to your host, Mr. Chris Taylor, Vice President, Investor Relations and Corporate Communications. Sir, you may begin.
Christopher Taylor - ZIOPHARM Oncology, Inc. - VP of IR and Corporate Communications
Thank you, Bridget. Good morning. Welcome to Ziopharm Oncology informational conference call and webcast to provide additional context related to recent news events.
This morning, our call will be led by Dr. Laurence Cooper, CEO of Ziopharm; and Dr. David Mauney, our Company President. David will provide some opening remarks and turn the call over to Laurence. Then we'll open the call for a few questions.
To accompany this webcast, Laurence will be speaking to a set of slides embedded into the webcast, which we have also posted in the Investors section of our website, ziopharm.com.
During the course of the call, the company will make a number of forward-looking
ZIOPHARM Oncology Inc to Discuss TCR-T Program Conference Call Transcript
Jun 12, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers